These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17117373)

  • 1. Multivariable modelling for meta-epidemiological assessment of the association between trial quality and treatment effects estimated in randomized clinical trials.
    Siersma V; Als-Nielsen B; Chen W; Hilden J; Gluud LL; Gluud C
    Stat Med; 2007 Jun; 26(14):2745-58. PubMed ID: 17117373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.
    Sterne JA; Jüni P; Schulz KF; Altman DG; Bartlett C; Egger M
    Stat Med; 2002 Jun; 21(11):1513-24. PubMed ID: 12111917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three different models for estimating relative risk in meta-analysis of clinical trials under unobserved heterogeneity.
    Kuhnert R; Böhning D
    Stat Med; 2007 May; 26(11):2277-96. PubMed ID: 16991109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
    Baujat B; Mahé C; Pignon JP; Hill C
    Stat Med; 2002 Sep; 21(18):2641-52. PubMed ID: 12228882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression.
    Localio AR; Margolis DJ; Berlin JA
    J Clin Epidemiol; 2007 Sep; 60(9):874-82. PubMed ID: 17689803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative methods to evaluate trial level surrogacy.
    Abrahantes JC; Shkedy Z; Molenberghs G
    Clin Trials; 2008; 5(3):194-208. PubMed ID: 18559408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
    Curtin F; Elbourne D; Altman DG
    Stat Med; 2002 Aug; 21(15):2161-73. PubMed ID: 12210631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
    Shrier I; Boivin JF; Steele RJ; Platt RW; Furlan A; Kakuma R; Brophy J; Rossignol M
    Am J Epidemiol; 2007 Nov; 166(10):1203-9. PubMed ID: 17712019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of stopping rules on heterogeneity of results in overviews of clinical trials.
    Hughes MD; Freedman LS; Pocock SJ
    Biometrics; 1992 Mar; 48(1):41-53. PubMed ID: 1581492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond classical meta-analysis: can inadequately reported studies be included?
    Robertson C; Idris NR; Boyle P
    Drug Discov Today; 2004 Nov; 9(21):924-31. PubMed ID: 15501727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of quantitative methods for identifying and exploring the presence of bias in systematic reviews: PDE-5 inhibitors for erectile dysfunction.
    Bekkering GE; Abou-Setta AM; Kleijnen J
    Int J Impot Res; 2008; 20(3):264-77. PubMed ID: 18059501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of continuous outcomes combining individual patient data and aggregate data.
    Riley RD; Lambert PC; Staessen JA; Wang J; Gueyffier F; Thijs L; Boutitie F
    Stat Med; 2008 May; 27(11):1870-93. PubMed ID: 18069721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A likelihood approach to meta-analysis with random effects.
    Hardy RJ; Thompson SG
    Stat Med; 1996 Mar; 15(6):619-29. PubMed ID: 8731004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive shock wave therapy for lateral elbow tendinopathy (tennis elbow): a systematic and qualitative analysis.
    Rompe JD; Maffulli N
    Br Med Bull; 2007; 83():355-78. PubMed ID: 17626054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of event rate heterogeneity across non-randomized study sub-groups.
    Eberly LE
    Stat Med; 2004 Jul; 23(13):2023-36. PubMed ID: 15211600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of methods of handling missing data in individual patient data meta-analyses: an empirical example on antibiotics in children with acute otitis media.
    Koopman L; van der Heijden GJ; Grobbee DE; Rovers MM
    Am J Epidemiol; 2008 Mar; 167(5):540-5. PubMed ID: 18184640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to increase response rates to postal questionnaires.
    Richards D
    Evid Based Dent; 2007; 8(2):53-4. PubMed ID: 17589494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.